Off-study utilization of experimental therapies: Analysis of GOG249-eligible cohorts using real world data.

CONCLUSIONS: There was significant use of experimental arm off-study treatment in the United States prior to report of GOG 249 results. Providers should be cautious when offering off-study treatment utilizing an experimental regimen given uncertainty about efficacy and toxicity. PMID: 31759772 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31759772?dopt=Abstract

Source: Gynecologic Oncology - November 19, 2019 Category: Cancer & Oncology Authors: Chodavadia PA, Jacobs CD, Wang F, Havrilesky LJ, Chino JP, Suneja G Tags: Gynecol Oncol Source Type: research